Dermatology Center for Outcomes Research and Safety (DCORS)
- DCORS Executive Director: Suephy C. Chen, MD, MS
- Clinical Research Coordinator: Bridget Bradley, RN, FNP, CCRC
- DCORS mission is to provide infrastructure for sponsored clinical trials, investigator-initiated studies, as well as quality and safety improvement measurement.
- DCORS misision is also to provide an environment that fosters new discovery and education in research.
- Our goal is to facilitate the translation of basic science research into practical applications that will benefit patients, as well as investigate “real world” issues related to medical intervention.
- Additionally, DCORS provides Emory investigators assistance in various aspects of conducting research, including designing protocols and budgets, obtaining IRB approval, patient recruitment, logistics of patient evaluation and data collection, and data analysis.
Three components that address our mission:
- DCORS Clinical Trials Unit
- Outcomes Research and Investigator-initiated Research
- Measurement for quality improvement and safety
DCORS Clinical Trial Unit
We are currently seeking participants for a research study for atopic dermatitis.
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
- Male or female subjects of 12 years or older
- Must have a recent history of inadequate response to treatment with topical medications
- Body weight ≥ 40 kg
- Moderate to severe AD for at least one year
- Affected BSA ≥10%
- History of thrombocytopenia, coagulopathy or platelet dysfunction
- Other confounding skin conditions (eg. Psoriasis, Seborrheic Dermatitis, etc.)
- History of malignancies with the exception of adequately treated or excised non metastatic basal cell or squamous cell cancer of the skin or cervical carcinoma in situ
- History of Mycobacterium tuberculosis(TB)
- History of HIV, Hepatitis B and C
- History of psychiatric disorder, alcohol and substance abuse